BioSpace News Archive

BioMidwest

New Analysis Shows that Abbott’s FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes

Abbott announced results from a new meta-analysis of 75 real-world, observational studies demonstrating that its FreeStyle® Libre system provides significant reductions in glycated hemoglobin that are sustained up to 24 months in adults with both type 1 and type 2 diabetes.

April 28, 2022
·
6 min read
Business

HanAll Biopharma Reports First Quarter 2022 Results and Provides Business Update

HanAll Biopharma (KRX: 009420.KS), a global biopharma company committed to deliver innovative and impactful therapeutics to address severe unmet medical needs, today reported the financial results for the first quarter of 2022.

April 28, 2022
·
8 min read
Business

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Thursday, May 5, 2022, at 5:00 p.m. ET to discuss a corporate update and financial results for the first quarter of 2022.

April 28, 2022
·
4 min read
Galmed reports interim results from the Open-Label part of the ARMOR study with Aramchol showing robust fibrosis improvement across multimodality histological assessment

Galmed Pharmaceuticals Ltd. announced interim results from the Open-Label Part of the ARMOR study showing fibrosis improvement with Aramchol using multimodality histological assessment.

April 28, 2022
·
8 min read
Business

Karyopharm to Report First Quarter 2022 Financial Results on May 5, 2022

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2022 financial results on Thursday, May 5, 2022.

April 28, 2022
·
2 min read
Pharm Country

CytoSorbents Highlights the Strategy of “Enhanced Lung Rest” Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress

CytoSorbents Corporation announced that the Company will participate in the 10th EuroELSO Congress in London, UK being held May 4-6, 2022, one of the two major conferences for ECMO users worldwide.

April 28, 2022
·
9 min read
Policy

BeiGene Announces BRUKINSA (zanubrutinib) Approval in Uruguay in Mantle Cell Lymphoma, Marginal Zone Lymphoma, and Waldenström’s Macroglobulinemia

BeiGene announced that the BTK inhibitor BRUKINSA has been approved in Uruguay for the treatment of adult patients with previously treated mantle cell lymphoma, relapsed or refractory marginal zone lymphoma, and Waldenström’s macroglobulinemia.

April 28, 2022
·
11 min read
Business

Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022

Orthofix Medical Inc. announced that it plans to release financial results for the first quarter 2022 before market open on Friday, May 6, 2022.

April 28, 2022
·
1 min read
Business

Concert Pharmaceuticals to Report First Quarter 2022 Results on May 5, 2022

Concert Pharmaceuticals, Inc. announced that it will report its financial results for the first quarter of 2022, on Thursday, May 5, 2022, before the U.S. financial markets open.

April 28, 2022
·
1 min read
Business

Seres Therapeutics to Host First Quarter 2022 Financial Results and Operational Progress Conference Call and Webcast on May 4, 2022

Seres Therapeutics, Inc. a leading microbiome therapeutics company, announced that management will host a conference call and live audio webcast on May 4, 2022 at 8:30 a.m. ET to discuss first quarter 2022 results and provide a general business update.

April 28, 2022
·
1 min read